Pricing Log in Create free account
Saturday 17 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,257.03 5.42 +0.43%
Market cap
$1.18T
P/E
42.2×
Fwd P/E
33.1×
Dividend yield
0.53%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Eli Lilly and Company (LLY) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Eli Lilly and Company (LLY) trades at a P/E ratio of 42.2×. Over the past ten years it has ranged from 0.0× (September 2018) to 264× (November 2018); the current reading is higher than 60% of that period. That is above the Drug Manufacturers General industry median of 24.5× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 46.8× (28.97%)
FY2024 65.9× (35.43%)
FY2023 102× 93.02%
FY2022 52.9× 17.58%
FY2021 45.0× 81.18%
FY2020 24.8× 65.87%
FY2019 15.0× (59.51%)
FY2018 37.0× —
FY2017 0.0× —
FY2016 28.9× (22.45%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 40.2× 23.18%
Mar 2026 32.7× (30.22%)
Dec 2025 46.8× 25.44%
Sep 2025 37.3× (26.73%)
42 more quarters

Against its own ten years

Low 0.0× High 264×
Ten-year median 39.2×
Current reading's percentile 57

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVS Novartis AG compare 22.6×
AZN AstraZeneca PLC compare 24.5×
AMGN Amgen Inc. compare 26.7×
JNJ Johnson & Johnson compare 29.6×
PFE Pfizer Inc. compare 38.9×
LLY Eli Lilly and Company 42.2×
ABBV AbbVie Inc. compare 80.6×
MRK Merck & Co., Inc. compare 117×
Drug Manufacturers General industry median 24.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on LLY